Mizuho Securities USA’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Mizuho Securities USA's BIIB Position: Q2 2026 in Review
Mizuho Securities USA increased its Biogen (BIIB) stake by 30% in Q2 2026, buying an estimated $514K and bringing the position to 11,558 shares worth $2.5M. The position accounts for 0.04% of the portfolio, ranked #379.
Mizuho Securities USA first reported a position in BIIB in Q2 2013 and has held it in 17 quarters since. The position peaked at $36.1M in Q3 2016. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Mizuho Securities USA held 11,558 shares of Biogen worth $2.5M as of Q2 2026.
- Mizuho Securities USA bought 2,686 Biogen shares in Q2 2026, an estimated $514K.
- Biogen made up 0.04% of Mizuho Securities USA's portfolio in Q2 2026, its #379 holding.
- Mizuho Securities USA first reported a position in Biogen in Q2 2013 and has held it in 17 quarters since.
- Mizuho Securities USA's Biogen position peaked at $36.1M in Q3 2016.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.